0000014272-22-000170.txt : 20220915
0000014272-22-000170.hdr.sgml : 20220915
20220915192945
ACCESSION NUMBER: 0000014272-22-000170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220913
FILED AS OF DATE: 20220915
DATE AS OF CHANGE: 20220915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elkins David V
CENTRAL INDEX KEY: 0001451604
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 221246768
MAIL ADDRESS:
STREET 1: C/O BECTON, DICKINSON AND COMPANY
STREET 2: 1 BECTON DRIVE
CITY: FRANKLIN LAKES
STATE: NJ
ZIP: 07417
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
wf-form4_166328457044815.xml
FORM 4
X0306
4
2022-09-13
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001451604
Elkins David V
430 E. 29TH STREET
14TH FLOOR
NEW YORK
NY
10016
0
1
0
0
EVP, Chief Financial Officer
Common Stock, $0.10 par value
2022-09-13
4
S
0
30000
71.35
D
100460
D
Common Stock, $0.10 par value
2022-09-13
4
M
0
2063
48.49
A
102523
D
Common Stock, $0.10 par value
2022-09-13
4
M
0
121214
48.49
A
223737
D
Common Stock, $0.10 par value
2022-09-13
4
S
0
103951
71.29
D
119786
D
Common Stock, $0.10 par value
204.15
I
BMS Savings and Investment Program
Option (right to buy)
48.49
2022-09-13
4
M
0
2063
0
D
2028-08-01
Common Stock, $0.10 par value
2063.0
0
D
Option (right to buy)
48.49
2022-09-13
4
M
0
121214
0
D
2028-08-01
Common Stock, $0.10 par value
121214.0
0
D
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.350 to $71.380, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Shares acquired from options exercised in a net exercise and hold transaction with broker.
103,951 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.240 to $71.405, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Based on a plan statement as of the end of the most recent fiscal quarter.
All of the shares are currently exercisable.
/s/ Lisa A. Atkins, attorney-in-fact for David V. Elkins
2022-09-15